Structured evidence table for Pea Protein Recovery Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Pea Protein Recovery Randomized Trial | Figure 1 Thus, in the present review we aimed to summarize the preclinical and clinical evidence of selected nutraceuticals, focusing on biotin, flavonoids especially luteolin, folic acid, Huperzine A, Lion’s mane, olive oil polyphenols (oleuropein and hydroxytyrosol [HT]), and palmitoylethanolamide (PEA). | 3 | Venetsanaki Vasiliki (2026) | Natural Molecules for Brain Health and Resilience |
| Pea Protein Recovery Randomized Trial | The present narrative review highlights current mechanistic insights, as well as evidence from experimental and clinical studies regarding their potential roles in supporting cognitive function, modulating neuroinflammation, and mitigating neurodegenerative processes. | 3 | Venetsanaki Vasiliki (2026) | Natural Molecules for Brain Health and Resilience |
| Pea Protein Recovery Randomized Trial | It should be noted that the present work consists of a review and not a dosing guideline. | 3 | Venetsanaki Vasiliki (2026) | Natural Molecules for Brain Health and Resilience |
| Pea Protein Recovery Randomized Trial | 1 1 Brain health is a multidimensional and evolving concept that is difficult to evaluate and quantify []. | 3 | Venetsanaki Vasiliki (2026) | Natural Molecules for Brain Health and Resilience |
| Pea Protein Recovery Randomized Trial | found that levels of PEA increase after focal ischemia in a mouse cerebral cortex, leading to hypermobility of microglial cells []. | 3 | Veredice Chiara (2026) | Investigating Properties of Palmitoylethanolamide in Physiology and Disease: Far Beyond an Anti-Inflammatory Shield |
| Pea Protein Recovery Randomized Trial | found that PPAR-α agonists exert a rapid anti-nociceptive effect in animal models of neuropathic pain, similar to the gabapentin effect but without development of tolerance. | 3 | Veredice Chiara (2026) | Investigating Properties of Palmitoylethanolamide in Physiology and Disease: Far Beyond an Anti-Inflammatory Shield |
| Pea Protein Recovery Randomized Trial | evaluated the oral anti-inflammatory efficacy of micronized versus non-micronized PEA formulations in the paw of a murine model of inflammation induced by intra-plantar injection of carrageenan, finding that paw edema and thermal hyperalgesia were most reduced by the micronized PEA formulation []. | 3 | Veredice Chiara (2026) | Investigating Properties of Palmitoylethanolamide in Physiology and Disease: Far Beyond an Anti-Inflammatory Shield |
| Pea Protein Recovery Randomized Trial | 1 2 Nutraceutics are functional components of food with positive effects on health which may fight inflammation, as evidenced by many studies evaluating chronic pain and oxidative burden in different protean conditions. | 3 | Veredice Chiara (2026) | Investigating Properties of Palmitoylethanolamide in Physiology and Disease: Far Beyond an Anti-Inflammatory Shield |
Source documents